Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Tremor in multiple sclerosis: The intriguing role of the cerebellum.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Optic Neuritis, its Differential Diagnosis and Management.
Concepts for regulation of axon integrity by enwrapping glia.
Atorvastatin: Multiple Sclerosis.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review.
Perth scientists embark on stroke therapy approach
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »